Hellaby execs sell down holdings to Bapcor but one retains stake

Senior executives at Hellaby Holdings sold down their stakes in the business to suitor Bapcor just days after the independent directors ended months of opposition to the takeover.

Just one non-executive director has held on to some of his shares in Hellaby, documents filed with the NZX show.

Alan Clarke, Hellaby's chief executive and managing director sold his entire stake of 106,000 shares on Jan. 18 for $381,600. Hellaby's independent directors backed the offer from ASX-listed Bapcor of $3.60 a share on January 16 after the offer went unconditional and Bapcor secured more than 50% of the company's shares. In September 2016, when the bid was first announced at $3.30 a share, Mr Clarke told BusinessDesk that he didn't disagree with commentary that the bid was opportunistic.

Clarke joined Hellaby in November 2015 from Abano Healthcare, where he had successfully fended off multiple takeover bids. He remains managing director of Hellaby to help manage the change in ownership.

The only executive who didn't sell down his entire holding was Paul Byrnes, who has been a non-executive director at Hellaby since 2003. The documents show that he sold just 20,000 shares to Bapcor for $72,000 on January 18. This reduced his stake to 980,086 shares, or 1% of Hellaby's shares, from 1,000,086 shares. At the price of $3.60 a share, Mr Byrnes' stake remains worth $3.52 million.

Mr Byrnes, alongside former chairman Steve Smith, are staying on as independent directors until the takeover closes. Mr Smith sold his stake of 200,000 shares on January 19 for $720,000.

Richard Jolly, Hellaby's chief financial officer and company secretary sold his stake of 150,000 shares on January 19 for $540,000.

Mark Cowsill, a former director, resigned on January 23 following the boardroom changes instigated by the new majority owner. He sold 10,000 shares on January 19 for $36,000.

Gary Mollard, another former director, sold his stake of 32,648 shares for $117,533 on January 19. He also resigned on January 23.

James Sclater sold his 145,701 shares for $524,524 on January 18. He also resigned on January 23.

As at January 24, Bapcor holds 83% of Hellaby and is seeking 90% so it can take full ownership and de-list the company from the NZX. The closing date for the takeover offer is February 7. Hellaby shares were unchanged at $3.58 while Bapcor was also unchanged on the ASX at $A5.47.

(BusinessDesk)